{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:09:20Z","timestamp":1790453360683,"version":"4.1.0"},"reference-count":74,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>The varicella-zoster virus is a human herpesvirus that causes varicella as the primary infection and HZ as the reactivation of a latent infection. Ten to twenty percent of cases of herpes zoster ophthalmicus (HZO) involve the ophthalmic branch of the fifth cranial nerve. Any area of the eye may be affected by the condition. HZ has a lifetime risk of more than 30%. Complications from herpes zoster can significantly lower quality of life. The goal of HZ vaccinations is to stop HZ activation and PHN formation. Despite the uncommon possibility of side effects such as eye problems, the majority of vaccines on the market now are safe. The purpose of this review is to discuss VZV infection and analyze and summarize the ocular complications following VZV vaccination.<\/jats:p>","DOI":"10.3390\/vaccines13080782","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T11:52:47Z","timestamp":1753271567000},"page":"782","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Varicella-Zoster Virus Infection and Varicella-Zoster Virus Vaccine-Related Ocular Complications"],"prefix":"10.3390","volume":"13","author":[{"given":"Jing","family":"Yu","sequence":"first","affiliation":[{"name":"Ophthalmology Department of the Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People\u2019s Hospital of Shenzhen, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Li","sequence":"additional","affiliation":[{"name":"Ophthalmology Department of the Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People\u2019s Hospital of Shenzhen, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Ji","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailan","family":"Liao","sequence":"additional","affiliation":[{"name":"Ophthalmology Department of the Second Affiliated Hospital, School of Medicine, The Chinese University of Hong Kong, Shenzhen & Longgang District People\u2019s Hospital of Shenzhen, Shenzhen 518172, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.coviro.2013.04.004","article-title":"T-cell immunity to human alphaherpesviruses","volume":"3","author":"Ouwendijk","year":"2013","journal-title":"Curr. Opin. Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1474-4422(07)70267-3","article-title":"The neurotropic herpes viruses: Herpes simplex and varicella-zoster","volume":"6","author":"Steiner","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.coi.2012.06.002","article-title":"Immune senescence and vaccines to prevent herpes zoster in older persons","volume":"24","author":"Levin","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/14760584.2019.1646129","article-title":"Do varicella vaccination programs change the epidemiology of herpes zoster? A comprehensive review, with focus on the United States","volume":"18","author":"Harpaz","year":"2019","journal-title":"Expert Rev. Vaccines"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/cid\/ciy953","article-title":"The Epidemiology of Herpes Zoster in the United States During the Era of Varicella and Herpes Zoster Vaccines: Changing Patterns Among Older Adults","volume":"69","author":"Harpaz","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/cid\/ciz305","article-title":"The Impact of Varicella Vaccination on the Incidence of Varicella and Herpes Zoster in the United States: Updated Evidence From Observational Databases, 1991\u20132016","volume":"70","author":"Wolfson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e3210","DOI":"10.1093\/cid\/ciaa1185","article-title":"Herpes Zoster and Postherpetic Neuralgia: Changing Incidence Rates From 1994 to 2018 in the United States","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1080\/21645515.2020.1847582","article-title":"A systematic literature review of herpes zoster incidence worldwide","volume":"17","author":"Vroling","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: Towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"ref_10","first-page":"9","article-title":"The nature of herpes zoster: A long-term study and a new hypothesis","volume":"58","year":"1965","journal-title":"Proc. R. Soc. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","article-title":"The global epidemiology of herpes zoster","volume":"81","author":"Yawn","year":"2013","journal-title":"Neurology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1503\/cmaj.091711","article-title":"The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: A prospective study","volume":"182","author":"Drolet","year":"2010","journal-title":"CMAJ Can. Med. Assoc. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJM199607043350107","article-title":"Postherpetic neuralgia\u2014Pathogenesis; treatment, and prevention","volume":"335","author":"Kost","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1056\/NEJMcp1302674","article-title":"Clinical practice: Herpes zoster","volume":"369","author":"Cohen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMcp1403062","article-title":"Clinical practice. Postherpetic neuralgia","volume":"371","author":"Johnson","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","article-title":"A systematic review and meta-analysis of risk factors for postherpetic neuralgia","volume":"157","author":"Forbes","year":"2016","journal-title":"Pain"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0304-3959(96)03122-3","article-title":"Pain and its persistence in herpes zoster","volume":"67","author":"Dworkin","year":"1996","journal-title":"Pain"},{"key":"ref_18","first-page":"604","article-title":"Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trials, 1987 to 1989","volume":"87","author":"White","year":"1991","journal-title":"Pediatrics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1080\/21645515.2017.1317410","article-title":"A critical appraisal of \u2018Shingrix\u2019, a novel herpes zoster subunit vaccine (HZ\/Su or GSK1437173A) for varicella zoster virus","volume":"13","author":"Bharucha","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMcp013211","article-title":"Clinical practice. Herpes zoster","volume":"347","author":"Gnann","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"bcr0120102678","DOI":"10.1136\/bcr.01.2010.2678","article-title":"Red eye in chickenpox: Varicella-related acute anterior uveitis in a child","volume":"2010","author":"Johnston","year":"2010","journal-title":"BMJ Case Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12348-016-0117-9","article-title":"Ocular involvement associated with varicella in adults","volume":"6","author":"Gargouri","year":"2016","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ophtha.2007.10.009","article-title":"Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity","volume":"115","author":"Liesegang","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/j.ophtha.2007.10.010","article-title":"Anterior segment complications of herpes zoster ophthalmicus","volume":"115","author":"Kaufman","year":"2008","journal-title":"Ophthalmology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/09273948.2017.1383447","article-title":"Review for Disease of the Year: Varicella Zoster Virus-Induced Anterior Uveitis","volume":"26","author":"Cimino","year":"2018","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.amjmed.2016.08.039","article-title":"Herpes Zoster Ophthalmicus: A Review for the Internist","volume":"130","author":"Vrcek","year":"2017","journal-title":"Am. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1016\/j.ophtha.2011.04.002","article-title":"Herpes zoster ophthalmicus: Comparison of disease in patients 60 years and older versus younger than 60 years","volume":"118","author":"Ghaznawi","year":"2011","journal-title":"Ophthalmology"},{"key":"ref_30","first-page":"181","article-title":"Herpes zoster keratitis","volume":"93","author":"Marsh","year":"1973","journal-title":"Trans. Ophthalmol. Soc. UK"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bjo.67.11.751","article-title":"Endothelial cell loss in herpes zoster keratouveitis","volume":"67","author":"Reijo","year":"1983","journal-title":"Br. J. Ophthalmol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12348-014-0025-9","article-title":"Ocular involvement and visual outcome of herpes zoster ophthalmicus: Review of 45 patients from Tunisia, North Africa","volume":"4","author":"Kahloun","year":"2014","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/02713688709020090","article-title":"Observations on the natural history of herpes zoster ophthalmicus","volume":"6","author":"Cobo","year":"1987","journal-title":"Curr. Eye Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.mayocp.2013.03.014","article-title":"Herpes zoster eye complications: Rates and trends","volume":"88","author":"Yawn","year":"2013","journal-title":"Mayo Clin. Proc."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ophtha.2016.03.005","article-title":"Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and Chronicity","volume":"123","author":"Tran","year":"2016","journal-title":"Ophthalmology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/bjo.2007.125773","article-title":"Association of varicella zoster virus load in the aqueous humor with clinical manifestations of anterior uveitis in herpes zoster ophthalmicus and zoster sine herpete","volume":"92","author":"Kido","year":"2008","journal-title":"Br. J. Ophthalmol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1442-9071.2001.d01-29.x","article-title":"Uveitis in Herpes zoster ophthalmicus","volume":"29","author":"Thean","year":"2001","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/ICO.0000000000001046","article-title":"Prevalence of Ocular Manifestations and Visual Outcomes in Patients With Herpes Zoster Ophthalmicus","volume":"36","author":"Szeto","year":"2017","journal-title":"Cornea"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"902","DOI":"10.15585\/mmwr.mm6534a4","article-title":"Epidemiology of Varicella During the 2-Dose Varicella Vaccination Program-United States, 2005\u20132014","volume":"65","author":"Lopez","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"ref_40","unstructured":"Centers for Disease Control and Prevention (1996). Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb. Mortal. Wkly. Rep., 45, 1\u201336."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1097\/ICO.0000000000000199","article-title":"Herpes zoster stromal keratitis after varicella vaccine booster in a pediatric patient","volume":"33","author":"Krall","year":"2014","journal-title":"Cornea"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1532-5415.2010.03021.x","article-title":"Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults","volume":"58","author":"Schmader","year":"2010","journal-title":"J. Am. Geriatr. Soc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1086\/522125","article-title":"The safety profile of varicella vaccine: A 10-year review","volume":"197","author":"Galea","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s40266-018-0603-x","article-title":"Recombinant Zoster Vaccine (Shingrix\u00ae): A Review in Herpes Zoster","volume":"35","author":"Syed","year":"2018","journal-title":"Drugs Aging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.4103\/ijo.IJO_816_20","article-title":"Drug-induced uveitis: A review","volume":"68","author":"Agarwal","year":"2020","journal-title":"Indian J. Ophthalmol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0002-9394(99)00059-8","article-title":"Uveitis associated with varicella virus vaccine","volume":"127","author":"Winkelman","year":"1999","journal-title":"Am. J. Ophthalmol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0002-9394(02)01957-8","article-title":"Herpes zoster virus sclerokeratitis and anterior uveitis in a child following varicella vaccination","volume":"135","author":"Naseri","year":"2003","journal-title":"Am. J. Ophthalmol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/bjo.2008.144501","article-title":"Acute posterior multifocal placoid pigment epitheliopathy following varicella vaccination","volume":"94","author":"Fine","year":"2010","journal-title":"Br. J. Ophthalmol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archophthalmol.2010.142","article-title":"Exacerbation of zoster interstitial keratitis after zoster vaccination in an adult","volume":"128","author":"Khalifa","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/archophthalmol.2011.320","article-title":"Acute retinal necrosis after herpes zoster vaccination","volume":"129","author":"Charkoudian","year":"2011","journal-title":"Arch. Ophthalmol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/archophthalmol.2012.2255","article-title":"Retinal necrosis following varicella-zoster vaccination","volume":"130","author":"Gonzales","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1001\/archophthalmol.2011.1881","article-title":"Uveitis exacerbation after varicella-zoster vaccination in an adult","volume":"130","author":"Sham","year":"2012","journal-title":"Arch. Ophthalmol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/ICO.0b013e318277acae","article-title":"Reactivation of herpes zoster keratitis in an adult after varicella zoster vaccination","volume":"32","author":"Hwang","year":"2013","journal-title":"Cornea"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/cid\/cix683","article-title":"Acute Retinal Necrosis Caused by the Zoster Vaccine Virus","volume":"65","author":"Heath","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/ICO.0000000000001203","article-title":"Reactivation of Herpes Zoster Keratitis With Corneal Perforation After Zoster Vaccination","volume":"36","author":"Jastrzebski","year":"2017","journal-title":"Cornea"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/ICB.0000000000000729","article-title":"Acute retinal necrosis and Contralateral cutaneous eruption after the shingles vaccine","volume":"15","author":"Ali","year":"2021","journal-title":"Retin. Cases Brief Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.ophtha.2018.08.030","article-title":"Reactivation of Herpes Zoster Stromal Keratitis After HZ\/su Adjuvanted Herpes Zoster Subunit Vaccine","volume":"125","author":"Lehmann","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/ICB.0000000000000567","article-title":"Two cases of acute retinal necrosis due to varicella zoster despite prior shingles vaccination","volume":"13","author":"Weinlander","year":"2019","journal-title":"Retin. Cases Brief Rep."},{"key":"ref_60","first-page":"e4920","article-title":"Uveitis Sarcoidosis Presumably Initiated After Administration of Shingrix Vaccine","volume":"11","author":"Vante","year":"2019","journal-title":"Cureus"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"100962","DOI":"10.1016\/j.ajoc.2020.100962","article-title":"Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine","volume":"20","author":"Chen","year":"2020","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/ICB.0000000000000761","article-title":"Acute retinal necrosis associated with herpes zoster vaccination","volume":"15","author":"Menghini","year":"2021","journal-title":"Retin. Cases Brief Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"101115","DOI":"10.1016\/j.ajoc.2021.101115","article-title":"Uveitis reactivation following recombinant zoster vaccination","volume":"23","author":"Richards","year":"2021","journal-title":"Am. J. Ophthalmol. Case Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000522272","article-title":"Reactivation of Herpes Zoster Keratitis Following Shingrix Vaccine","volume":"13","author":"Lu","year":"2022","journal-title":"Case Rep. Ophthalmol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Andrade, C., Cordeiro, M.d.A., Baptista, R.B., Nunes, B.S., Garcia, A.M., Silva, T.M., and Pinto, M.V. (2025). Post-varicella vaccination uveitis in a child with nephrotic syndrome receiving immunosuppressive treatment: A case report. Front. Pediatr., 13.","DOI":"10.3389\/fped.2025.1567164"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"324","DOI":"10.17161\/kjm.vol13.13808","article-title":"Generalized Rash and Bilateral Retinal Necrosis in an Adult Healthcare Worker after Post-Exposure Herpes Zoster Vaccination: A Rare Case Report","volume":"13","author":"Hayat","year":"2020","journal-title":"Kans. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/ICO.0000000000001595","article-title":"Risk of Anterior Segment Complications Associated With the Live Herpes Zoster Vaccine: Evidence From a Health-Claim Database","volume":"37","author":"Liu","year":"2018","journal-title":"Cornea"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1016\/j.vaccine.2017.11.013","article-title":"Herpes zoster vaccine live: A 10 year review of post-marketing safety experience","volume":"35","author":"Willis","year":"2017","journal-title":"Vaccine"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"545","DOI":"10.7326\/0003-4819-152-9-201005040-00004","article-title":"Safety of herpes zoster vaccine in the shingles prevention study: A randomized trial","volume":"152","author":"Simberkoff","year":"2010","journal-title":"Ann. Intern. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.mayocp.2015.04.021","article-title":"Risk of Herpes Zoster and Disseminated Varicella Zoster in Patients Taking Immunosuppressant Drugs at the Time of Zoster Vaccination","volume":"90","author":"Cheetham","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/infdis\/jiv244","article-title":"Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine","volume":"212","author":"Tseng","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.vaccine.2019.11.058","article-title":"Review of the initial post-marketing safety surveillance for the recombinant zoster vaccine","volume":"38","author":"Co","year":"2020","journal-title":"Vaccine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1016\/j.vaccine.2019.03.043","article-title":"Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials","volume":"37","author":"Campora","year":"2019","journal-title":"Vaccine"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e0181624","DOI":"10.1128\/jvi.01816-24","article-title":"Insights into pathologic mechanisms occurring during serious adverse events following live zoster vaccination","volume":"99","author":"Kennedy","year":"2025","journal-title":"J. Virol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/8\/782\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:36Z","timestamp":1760033676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/13\/8\/782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":74,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["vaccines13080782"],"URL":"https:\/\/doi.org\/10.3390\/vaccines13080782","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}